FibroGen, Inc. (FGEN)

8.38 -0.32 (-3.68%) USD  |  NASDAQ  |  Dec 12, 16:00
8.29 -0.09 (-1.07%) After-Hours: 05:08
More

FibroGen Research and Development Expense (Annual): 95.69M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for FGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Assertio Holdings, Inc. 3.822M
Harrow, Inc. 12.95M
Skye Bioscience, Inc. 18.70M
Theravance Biopharma, Inc. 36.04M
NovaBay Pharmaceuticals, Inc. 0.042M